Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 juin 2021 09h06 HE | Source: Hagens Berman Sobol Shapiro LLP

EBS INVESTOR DEADLINE TOMORROW: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors with Losses to Contact the Firm Now, Securities Fraud Lawsuit Pending

SAN FRANCISCO, June 17, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: Apr. 24,...
12 juin 2021 12h06 HE | Source: Hagens Berman Sobol Shapiro LLP

EBS 6-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Before June 18th Deadline in Securities Fraud Action

SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: Apr. 24,...
07 juin 2021 14h51 HE | Source: Hagens Berman Sobol Shapiro LLP

EBS 11-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, June 18th Deadline Approaching in Securities Fraud Lawsuit

SAN FRANCISCO, June 07, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: Apr. 24,...
01 juin 2021 17h38 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, Securities Fraud Class Action Filed, Deadline Approaching

SAN FRANCISCO, June 01, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: Apr. 24,...
23 mai 2021 11h05 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, Securities Fraud Class Action Filed

SAN FRANCISCO, May 23, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: Apr. 24,...
18 mai 2021 11h56 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, Securities Fraud Class Action Filed

SAN FRANCISCO, May 18, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: Apr. 24,...
13 mai 2021 13h41 HE | Source: Hagens Berman Sobol Shapiro LLP

EBS INVESTORS ACT NOW: Contact HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, to Recover Losses Due to Alleged Securities Fraud

SAN FRANCISCO, May 13, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: July 6,...
08 mai 2021 11h41 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Class Action Filed

SAN FRANCISCO, May 08, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: July 6,...
03 mai 2021 21h52 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Class Action Filed, Application Deadline Approaching

SAN FRANCISCO, May 03, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: July 6,...
26 avr. 2021 19h41 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Fraud Case Pending, Firm Investigating CEO’s Insider Sales

SAN FRANCISCO, April 26, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: July...